Nogo-B inhibition restricts ulcerative colitis via inhibiting p68/miR-155 signaling pathway.
Zheng J, Wang S, Zhang T, Li H, Zhu M, Wei X, Ge Y, Yang X, Zhang S, Xu H, Duan Y, Liu L, Chen Y.
Zheng J, et al. Among authors: zhang s, zhang t.
Int Immunopharmacol. 2023 Jul;120:110378. doi: 10.1016/j.intimp.2023.110378. Epub 2023 May 25.
Int Immunopharmacol. 2023.
PMID: 37244119